Integrin αvβ3 and LHRH Receptor Double Directed Nano-Analogue Effective Against Ovarian Cancer in Mice Model
International Journal of Nanomedicine · 2024
DOI: 10.2147/ijn.s442921 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2024. Verfasst von Na Qi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, 510315, People's Republic of China. Hauptthemen laut MEDLINE: Ovarian Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, 510315, People's Republic of China.
- Department of Pharmacy, Guilin Medical University, Guilin, 541004, People's Republic of China.
Zitieren
APA
Qi, N., Zhou, X., Ma, N., Zhang, J., Wang, Z., Zhang, X., & Li, A. (2024). Integrin αvβ3 and LHRH Receptor Double Directed Nano-Analogue Effective Against Ovarian Cancer in Mice Model. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s442921
Vancouver
Qi N, Zhou X, Ma N, Zhang J, Wang Z, Zhang X, et al. Integrin αvβ3 and LHRH Receptor Double Directed Nano-Analogue Effective Against Ovarian Cancer in Mice Model. International Journal of Nanomedicine. 2024. doi:10.2147/ijn.s442921
BibTeX
@article{Qi2024,
author = {Qi, Na and Zhou, Xiantai and Ma, Ningzhu and Zhang, Jianguo and Wang, Zhenlin and Zhang, Xin and Li, Aimin},
title = {Integrin αvβ3 and LHRH Receptor Double Directed Nano-Analogue Effective Against Ovarian Cancer in Mice Model},
journal = {International Journal of Nanomedicine},
year = {2024},
doi = {10.2147/ijn.s442921}
}
EUVIMED